Prescription anti nausea medication
Pro Research Analysisby 
Searched over 200M research papers
Prescription Anti-Nausea Medication: Efficacy and Usage Patterns
Chemotherapy-Induced Nausea and Vomiting (CINV)
Commonly Prescribed Antiemetics for CINV
Chemotherapy-induced nausea and vomiting (CINV) is a significant side effect that can severely impact patients undergoing cancer treatment. Various antiemetic regimens are prescribed to manage these symptoms. A study conducted at a tertiary care center found that palonosetron was the most commonly used antiemetic (63.3%), followed by aprepitant, granisetron, and ondansetron. Dexamethasone was prescribed to all patients . The combination of aprepitant, palonosetron, and dexamethasone was particularly effective, with patients reporting no nausea or emesis .
Olanzapine for CINV
Olanzapine has shown significant efficacy in preventing CINV. In a randomized, double-blind, phase 3 trial, olanzapine was compared with a placebo and demonstrated a higher rate of nausea prevention and complete response (no emesis and no use of rescue medication) . A systematic review and meta-analysis further confirmed that olanzapine is effective and safe, particularly in the delayed and overall phases of CINV prevention, although it was not superior in the acute phase . Another study suggested that a reduced dose of olanzapine (5 mg) combined with standard antiemetic therapy could be a new standard for patients undergoing cisplatin-based chemotherapy, showing a high complete response rate with minimal severe side effects .
Opioid-Induced Nausea and Vomiting (OINV)
Prophylactic Use of Antiemetics
Opioid-induced nausea and vomiting (OINV) is another common issue, particularly in cancer pain management. A survey among Japanese physicians revealed that 82% prescribed prophylactic antiemetics when starting opioid treatment, with prochlorperazine being the most commonly used drug (88%) . Despite the lack of strong evidence supporting this practice, it is widely adopted in clinical settings .
Nausea and Vomiting During Pregnancy
Decision-Making and Medication Use
Nausea during pregnancy affects a significant proportion of women, leading to difficult decisions regarding medication use. A pilot qualitative study highlighted that women carefully weigh the risks and benefits of taking anti-nausea medications, often considering information from healthcare providers, internet research, and personal networks. While some women opted against medication, those who did take prescriptions reported substantial symptom improvement .
Safe Prescribing Practices
In the United States, there has been a notable increase in the use of ondansetron for treating nausea and vomiting during pregnancy, despite concerns about fetal safety. The FDA has approved a combination of doxylamine and pyridoxine specifically for this purpose, which is considered safe and effective. This approval suggests a need for changes in prescribing practices to avoid exposing pregnant women to potentially unsafe medications .
Conclusion
The management of nausea and vomiting through prescription antiemetics varies across different conditions such as chemotherapy, opioid use, and pregnancy. While certain medications like olanzapine and combinations including aprepitant have shown high efficacy in CINV, the prophylactic use of antiemetics for OINV and the careful decision-making process for pregnancy-related nausea highlight the complexity and necessity for tailored approaches. Ongoing research and updated clinical guidelines are essential to optimize treatment efficacy and safety for all patients.
Sources and full results
Most relevant research papers on this topic